Advertisement
Review Article| Volume 20, ISSUE 2, P237-253, April 2004

Blood transfusion risks in the intensive care unit

      The American Association of Blood Bank (AABB) Standards defines any adverse reaction experienced by a patient during a transfusion as a suspected transfusion reaction. The complex clinical condition of patients in the intensive care unit could mask the symptoms of a serious transfusion reaction. There should be a high degree of suspicion that new symptoms or exacerbation of existing symptoms could be caused by blood in a patient receiving a transfusion. This will permit early detection and prevention of serious adverse reactions to transfusion.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sandler S.G
        Risks of blood transfusion-2002.
        Curr Opin Hematol. 2002; 9: 509-510
        • Baker R.J
        • Moinichen S.L
        • Nyhus L.M
        Transfusion reaction: a reappraisal of surgical incidence and significance.
        Proc Inst Med Chic. 1969; 27: 214-215
        • Spiess B.D
        Blood transfusion: the silent epidemic.
        Ann Thorac Surg. 2001; 72: S1832-S1837
        • Dodd R.Y
        • Notari E.P
        • Stramer S.L
        Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population.
        Transfusion. 2002; 42: 975-979
        • Perrotta P.L
        • Snyder E.L
        Noninfectious complications of transfusion therapy.
        Blood Rev. 2001; 15: 69-83
        • Ambruso D.R
        Hemolytic transfusion reactions.
        in: Hillyer C.D Silbertstein L.E Ness P.M Blood banking and transfusion medicine. Basic principles and practice. Churchill Livingstone, New York2003: 391-394
        • Lichtiger B
        • Perry-Thornton E
        Hemolytic transfusion reactions in oncology patients: experience in a large cancer center.
        J Clin Oncol. 1984; 2: 438-442
        • Moore S.B
        • Taswell H.F
        • Pineda A.A
        • Sonnenberg C.L
        Delayed hemolytic transfusion reactions. Evidence of the need for an improved pretransfusion compatibility test.
        Am J Clin Pathol. 1980; 74: 94-97
        • Sazama K
        Reports of 355 transfusion-associated deaths: 1976 through 1985.
        Transfusion. 1990; 30: 583-590
        • Williamson L.M
        • Lowe S
        • Love E.M
        • Cohen H
        • Soldan K
        • McClelland D.B
        • et al.
        Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports.
        BMJ. 1999; 319: 16-19
        • Simon T.L
        Proficiency testing program CAP survey. College of American Pathologists, Northfield (IL)1991
        • Wallace J
        Blood transfusion for clinicians. Churchill Livingstone, Edinburgh (UK)1977
        • Pineda A.A
        • Brzica Jr, S.M
        • Taswell H.F
        Hemolytic transfusion reaction. Recent experience in a large blood bank.
        Mayo Clin Proc. 1978; 53: 378-390
      1. Brecher M.E Technical manual. 14th edition. American Association of Blood Banks, Bethesda (MD)2003
        • Ahrons S
        • Kissmeyer-Nielsen F
        Serological investigations of 1358 transfusion reactions in 74,000 transfusions.
        Dan Med Bull. 1968; 15: 259-262
        • Menitove J.E
        • McElligott M.C
        • Aster R.H
        Febrile transfusion reaction: what blood component should be given next?.
        Vox Sang. 1982; 42: 318-321
        • Silliman C.C
        • Boshkov L.K
        • Mehdizadehkashi Z
        • Elzi D.J
        • Dickey W.O
        • Podlosky L
        • et al.
        Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors.
        Blood. 2003; 101: 454-462
        • Blajchman M.A
        Incidence and significance of the bacterial contamination of blood components.
        Dev Biol (Basel). 2002; 108: 59-67
        • Blajchman M.A
        • Goldman M
        Bacterial contamination of platelet concentrates: incidence, significance, and prevention.
        Semin Hematol. 2001; 38: 20-26
        • Maung Z.T
        • Wood A.C
        • Jackson G.H
        • Turner G.E
        • Appleton A.L
        • Hamilton P.J
        Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia.
        Br J Haematol. 1994; 88: 649-652
        • Engoren M.C
        • Habib R.H
        • Zacharias A
        • Schwann T.A
        • Riordan C.J
        • Durham S.J
        Effect of blood transfusion on long-term survival after cardiac operation.
        Ann Thorac Surg. 2002; 74: 1180-1186
        • Taylor R.W
        • Manganaro L
        • O'Brien J
        • Trottier S.J
        • Parkar N
        • Veremakis C
        Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient.
        Crit Care Med. 2002; 30: 2249-2254
        • Claridge J.A
        • Sawyer R.G
        • Schulman A.M
        • McLemore E.C
        • Young J.S
        Blood transfusions correlate with infections in trauma patients in a dose-dependent manner.
        Am Surg. 2002; 68: 566-572
        • Chelemer S.B
        • Prato B.S
        • Cox Jr, P.M
        • O'Connor G.T
        • Morton J.R
        Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery.
        Ann Thorac Surg. 2002; 73: 138-142
        • Fujino Y
        • Mizoue T
        • Tokui N
        • Yoshimura T
        A prospective study of blood transfusion history and liver cancer in a high-endemic area of Japan.
        Transfus Med. 2002; 12: 297-302
        • Busch O.R
        • Hop W.C
        • Hoynck van Papendrecht M.A
        • Marquet R.L
        • Jeekel J
        Blood transfusions and prognosis in colorectal cancer [see comments].
        N Engl J Med. 1993; 328: 1372-1376
        • Heiss M.M
        • Mempel W
        • Jauch K.W
        • Delanoff C
        • Mayer G
        • Mempel M
        • et al.
        Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery [published erratum appears in Lancet 1994;343(8888):64] [see comments].
        Lancet. 1993; 342: 1328-1333
        • Jensen L.S
        • Andersen A.J
        • Christiansen P.M
        • Hokland P
        • Juhl C.O
        • Madsen G
        • et al.
        Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery.
        Br J Surg. 1992; 79: 513-516
        • Jensen L.S
        • Kissmeyer-Nielsen P
        • Wolff B
        • Qvist N
        Randomised comparison of leucocyte-depleted versus buffy-coat- poor blood transfusion and complications after colorectal surgery [see comments].
        Lancet. 1996; 348: 841-845
        • Houbiers J.G
        • Brand A
        • van de Watering L.M
        • Hermans J
        • Verwey P.J
        • Bijnen A.B
        • et al.
        Randomised controlled trial comparing transfusion of leucocyte- depleted or buffy-coat-depleted blood in surgery for colorectal cancer [see comments].
        Lancet. 1994; 344: 573-578
      2. Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 2000. MMWR Morb Mortal Wkly Rep 2002;49(53):i–xxii, 1–100

        • Gresens C.J
        • Holland P.V
        Current risks of viral hepatitis from blood transfusions.
        J Gastroenterol Hepatol. 1998; 13: 443-449
        • Margolis H.S
        • Coleman P.J
        • Brown R.E
        • Mast E.E
        • Sheingold S.H
        • Arevalo J.A
        Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
        JAMA. 1995; 274: 1201-1208
        • Alter M.J
        • Kruszon-Moran D
        • Nainan O.V
        • McQuillan G.M
        • Gao F
        • Moyer L.A
        • et al.
        The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.
        N Engl J Med. 1999; 341: 556-562
        • van der Poel C.L
        Hepatitis C virus and blood transfusion: past and present risks.
        J Hepatol. 1999; 31: 101-106
        • Pantanowitz L
        • Telford III, S.R
        • Cannon M.E
        The impact of babesiosis on transfusion medicine.
        Transfus Med Rev. 2002; 16: 131-143
        • Arguin P.M
        • Singleton J
        • Rotz L.D
        • Marston E
        • Treadwell T.A
        • Slater K
        • et al.
        An investigation into the possibility of transmission of tick-borne pathogens via blood transfusion. Transfusion-Associated Tick-Borne Illness Task Force.
        Transfusion. 1999; 39: 828-833
        • Dobroszycki J
        • Herwaldt B.L
        • Boctor F
        • Miller J.R
        • Linden J
        • Eberhard M.L
        • et al.
        A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
        JAMA. 1999; 281: 927-930
        • Leiby D.A
        • Rentas F.J
        • Nelson K.E
        • Stambolis V.A
        • Ness P.M
        • Parnis C
        • et al.
        Evidence of Trypanosoma cruzi infection (Chagas' disease) among patients undergoing cardiac surgery.
        Circulation. 2000; 102: 2978-2982
        • Mungai M
        • Tegtmeier G
        • Chamberland M
        • Parise M
        Transfusion-transmitted malaria in the United States from 1963 through 1999.
        N Engl J Med. 2001; 344: 1973-1978
        • Stramer S.L
        • Caglioti S
        • Strong D.M
        NAT of the United States and Canadian blood supply.
        Transfusion. 2000; 40: 1165-1168
        • Chamberland M.E
        • Alter H.J
        • Busch M.P
        • Nemo G
        • Ricketts M
        Emerging infectious disease issues in blood safety.
        Emerg Infect Dis. 2001; 7: 552-553
        • Houston F
        • Foster J.D
        • Chong A
        • Hunter N
        • Bostock C.J
        Transmission of BSE by blood transfusion in sheep.
        Lancet. 2000; 356: 999-1000
        • Hunter N
        • Foster J
        • Chong A
        • McCutcheon S
        • Parnham D
        • Eaton S
        • et al.
        Transmission of prion diseases by blood transfusion.
        J Gen Virol. 2002; 83: 2897-2905
      3. Scientists race to develop a blood test for vCJD.
        Nat Med. 2001; 7: 261
        • Centers for Disease Control and Prevention
        Provisional surveillance summary of the West Nile virus epidemic–United States. January–November 2002.
        MMWR Morb Mortal Wkly Rep. 2002; 51: 1129-1133
        • Centers for Disease Control and Prevention
        West Nile virus activity–United States. October 10–16, 2002, and update on West Nile virus infections in recipients of blood transfusions.
        MMWR Morb Mortal Wkly Rep. 2002; 51: 929-931
        • Centers for Disease Control and Prevention
        Investigations of West Nile virus infections in recipients of blood transfusions.
        MMWR Morb Mortal Wkly Rep. 2002; 51: 973-974
        • Callum J.L
        • Kaplan H.S
        • Merkley L.L
        • Pinkerton P.H
        • Rabin F.B
        • Romans R.A
        • et al.
        Reporting of near-miss events for transfusion medicine: improving transfusion safety.
        Transfusion. 2001; 41: 1204-1211
        • Linden J.V
        • Kaplan H.S
        Transfusion errors: causes and effects.
        Transfus Med Rev. 1994; 8: 169-183
        • Linden J.V
        • Wagner K
        • Voytovich A.E
        • Sheehan J
        Transfusion errors in New York State: an analysis of 10 years' experience.
        Transfusion. 2000; 40: 1207-1213
        • Council of Europe Expert Committee in Blood Transfusion Study Group on Pathogen Inactivation of Labile Blood Components
        Pathogen inactivation of labile blood products.
        Transfus Med. 2001; 11: 149-175
        • Barbara J
        The rationale for pathogen inactivation treatment of platelet components–introduction.
        Semin Hematol. 2001; 38: 1-3
        • Jensen N.J
        • Crosson J.T
        An automated system for bedside verification of the match between patient identification and blood unit identification.
        Transfusion. 1996; 36: 216-221
        • Simon T.L
        • Alverson D.C
        • AuBuchon J
        • Cooper E.S
        • DeChristopher P.J
        • Glenn G.C
        • et al.
        Practice parameter for the use of red blood cell transfusions. Developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists.
        Arch Pathol Lab Med. 1998; 122: 130-138